Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 52.02%42M | 55.83%34.93M | 36.29%27.59M | 48.39%94.54M | 53.36%24.25M | 59.01%27.63M | 31.21%22.42M | 50.67%20.25M | 8.51%63.71M | 10.40%15.81M |
| Cost of revenue | 34.17%20.42M | 44.46%19.24M | 2.53%14.97M | 10.73%54.98M | 0.06%11.85M | 3.33%15.22M | 6.64%13.32M | 37.75%14.6M | -2.32%49.65M | -2.65%11.84M |
| Gross profit | 73.91%21.58M | 72.47%15.7M | 123.64%12.62M | 181.45%39.55M | 212.22%12.4M | 368.74%12.41M | 97.91%9.1M | 99.00%5.64M | 78.47%14.05M | 83.80%3.97M |
| Operating expense | 59.63%2.78M | 91.56%3.7M | -11.40%2.05M | -48.78%5.65M | -110.61%-337.6K | -54.61%1.74M | -22.91%1.93M | 54.12%2.31M | 93.61%11.03M | 172.63%3.18M |
| Staff costs | 37.26%89.23K | 109.68%136.31K | 25.67%67.71K | 26.13%248.91K | 9.58%65.01K | 24.66%65.01K | 71.99%65.01K | 12.10%53.88K | -20.81%197.34K | 298.37%59.33K |
| Selling and administrative expenses | 60.49%2.7M | 91.46%3.57M | 1.83%1.98M | 14.64%7.44M | 18.09%1.96M | -13.18%1.68M | 28.49%1.86M | 33.97%1.94M | 19.18%6.49M | 38.57%1.66M |
| -General and administrative expense | 60.49%2.7M | 91.46%3.57M | 1.83%1.98M | 14.64%7.44M | 18.09%1.96M | -13.18%1.68M | 28.49%1.86M | 33.97%1.94M | 19.18%6.49M | 38.57%1.66M |
| Other operating expenses | ---- | ---- | ---- | -147.07%-2.04M | -261.33%-2.36M | ---- | -99.49%5.23K | --312.52K | --4.34M | --1.46M |
| Total other operating income | ---- | ---- | --0 | -92.92%331.14K | -101.22%-20.04K | --0 | -98.92%11.33K | --339.85K | --4.68M | --1.64M |
| Operating profit | 76.24%18.8M | 67.33%11.99M | 217.16%10.57M | 1,021.13%33.9M | 1,509.78%12.74M | 991.95%10.66M | 242.81%7.17M | 149.26%3.33M | 38.87%3.02M | -20.42%791.3K |
| Net non-operating interest income (expenses) | 874.88%143.1K | 310.18%85.73K | 338.46%95.1K | 58.87%-175.26K | 28.81%-76.12K | 65.17%-18.47K | 72.41%-40.79K | 66.30%-39.88K | 87.03%-426.14K | 93.37%-106.92K |
| Non-operating interest income | 145.92%268.69K | 114.12%203.22K | 52.96%206.08K | 59.42%499.14K | 21.64%160.24K | 7.57%109.26K | 156.65%94.91K | 214.63%134.72K | 147.73%313.11K | 465.50%131.73K |
| Non-operating interest expense | -1.67%125.6K | -13.41%117.5K | -36.44%110.97K | -8.77%674.4K | -26.95%236.37K | -2.10%127.73K | -26.58%135.7K | 8.34%174.61K | -78.33%739.25K | -80.21%323.57K |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | -49.76%12.12K | ---- | ---- | ---- | ---- |
| Net investment income | -116.54%-21.4K | 104.78%37.58K | 303.74%70.43K | -970.38%-1.52M | -801.89%-824.44K | 398.08%129.43K | -4,601.80%-785.79K | -141.84%-34.57K | 31.96%174.11K | 39.37%117.46K |
| Gain(Loss) on financial instruments designated as cash flow hedges | 0 | 0 | 0 | -98.72%6.83K | 0 | 0 | 0 | 6.83K | 222.92%534.42K | 11.97K |
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 965.90%266.56K | 150.46%48.6K | 239.62%39.51K | -251.72%-274.56K | -142.23%-214.89K | -79.53%25.01K | -2,612.65%-96.31K | -91.90%11.63K | 432.36%180.97K | -69.99%-88.71K |
| Less:Other special charges | -965.90%-266.56K | -150.46%-48.6K | -239.62%-39.51K | 251.72%274.56K | 142.23%214.89K | 79.53%-25.01K | 2,612.65%96.31K | 91.90%-11.63K | -432.36%-180.97K | 69.99%88.71K |
| Other non-operating income (expenses) | -92.92%331.14K | -101.22%-20.04K | -98.92%11.33K | 339.85K | 4.68M | 1.64M | ||||
| Income before tax | 77.62%19.18M | 94.45%12.17M | 197.94%10.78M | 295.17%32.28M | 391.09%11.6M | 1,456.71%10.8M | 70.65%6.26M | 150.29%3.62M | 1,152.15%8.17M | 503.55%2.36M |
| Income tax | 46.36%3.2M | 198.61%2.01M | 10,357.50%2.01M | 179.94%4.46M | 297.30%1.62M | 107.52%2.18M | 337.60%671.74K | 10.71%-19.59K | 670.16%1.59M | 186.23%407.79K |
| Net income | 85.55%15.99M | 81.93%10.16M | 141.09%8.77M | 323.07%27.82M | 410.66%9.98M | 2,499.08%8.62M | 58.99%5.58M | 147.88%3.64M | 768.90%6.58M | 1,837.21%1.95M |
| Net income continuous operations | 85.55%15.99M | 81.93%10.16M | 141.09%8.77M | 323.07%27.82M | 410.66%9.98M | 2,499.08%8.62M | 58.99%5.58M | 147.88%3.64M | 768.90%6.58M | 1,837.21%1.95M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 85.55%15.99M | 81.93%10.16M | 141.09%8.77M | 323.07%27.82M | 410.66%9.98M | 2,499.08%8.62M | 58.99%5.58M | 147.88%3.64M | 768.90%6.58M | 1,837.21%1.95M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 85.55%15.99M | 81.93%10.16M | 141.09%8.77M | 323.07%27.82M | 410.66%9.98M | 2,499.08%8.62M | 58.99%5.58M | 147.88%3.64M | 768.90%6.58M | 1,837.21%1.95M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 85.50%0.2111 | 81.95%0.1341 | 141.25%0.1158 | 323.16%0.3673 | 410.85%0.1318 | 2,521.28%0.1138 | 58.84%0.0737 | 147.42%0.048 | 767.69%0.0868 | 1,820.00%0.0258 |
| Diluted earnings per share | 85.50%0.2111 | 81.95%0.1341 | 141.25%0.1158 | 323.16%0.3673 | 410.85%0.1318 | 2,521.28%0.1138 | 58.84%0.0737 | 166.67%0.048 | 767.69%0.0868 | 1,820.00%0.0258 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.